APA (7th ed.) Citation

Rivas, M. O. G., Stuart, S. D., Thach, D., Dahan, M., Shorr, R., Zachar, Z., & Bingham, P. M. Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Rivas, Moises O Guardado, Shawn D. Stuart, Daniel Thach, Michael Dahan, Robert Shorr, Zuzana Zachar, and Paul M. Bingham. Evidence for a Novel, Effective Approach to Targeting Carcinoma Catabolism Exploiting the First-in-class, Anti-cancer Mitochondrial Drug, CPI-613. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Rivas, Moises O Guardado, et al. Evidence for a Novel, Effective Approach to Targeting Carcinoma Catabolism Exploiting the First-in-class, Anti-cancer Mitochondrial Drug, CPI-613. Public Library of Science (PLoS).